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The effectiveness of percutaneous embolotherapy in cases
of hemoptysis due to pulmonary tuberculosis from increasing
severity of lung parenchymal injury was compared. The
pattern of pleural involvement, as seen on chest radiography
and angiography, were comparatively analyzed in 230
patients who were available for follow-ups from March 1992
to December 2003. Chest radiography findings were clas-
sified into 4 types based on levels of complicated lesions and
pleural involvement. Angiography findings were divided into
4 groups based on the level of blood supply to lesions. Early
hemostasis with respect to radiographic group were as
follows: Type I- 92% (73/79), Type II- 80% (52/65), Type
III- 70% (42/60), and Type IV- 56% (52/92); there was an
average success rate of 73% (219/296), and continued
hemostasis was found in 80% of Type I patients (62/77), 77%
of Type II patients (41/53), 62% of Type III patients (25/40),
and 45% of Type IV patients (27/60), with an average long-
term hemostatic rate of 67% (155/230). Increasing severity of
pleural involvement and associated complications correlated
with increasing development of systemic collateral arteries
other than the bronchial artery. The severely increased
circulation in systemic collateral arteries makes it difficult to
predict good hemostatic results following embolization.
Therefore, we recommend aggressive treatment, such as sur-
gical intervention, after embolization in such instances.
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INTRODUCTION
Pulmonary tuberculosis is the most common
cause of hemoptysis, and the onset of this compli-
cation may occur after the tuberculosis has been
cured or during its inactive stage, with the devel-
opment of bronchiectasis, chronic bronchitis or as-
pergilloma, or as the result of the reactivation (re-
currence) of tuberculosis, microbial colonization
within a bronchial cavitation, scar cancer or com-
plicating hemorrhagic disease.
1 Recently, bronchial
artery embolizations, as well as other arterial em-
bolizations, have been performed as a preopera-
tive hemostatic measure in the treatment of hemop-
tysis from a variety of causes, including pulmonary
tuberculosis, or as a treatment alternative in cases
where surgery is not possible due to poor lung
function.
2,3 The experience of the present authors
revealed that differences exist in both the early and
late hemostatic effects of bronchial and systemic
collateral artery embolization, depending on
whether the patient had tuberculosis without com-
plications, secondary lung lesions due to tubercu-
losis, or tuberculosis accompanied by pleural in-
volvement. The goal of this study was to in-
vestigate the relationship between the degree of
lung lesions caused by tuberculosis with the degree
of pleural involvement and their influence on the
hemostatic effect of arterial embolization.
MATERIALS AND METHODS
Among 296 patients who underwent arterial
embolization for hemoptysis due to pulmonary
tuberculosis from March 1992 to December 2003,
230 were available for follow-up (3-79 months,
mean 18.5 months) and were subjects for the
present study. There were 143 males and 87
The Effectiveness of Embolotherapy for Treatment of
Hemoptysis in Patients with Varying Severity of
Tuberculosis by Assessment of Chest Radiography
Woocheol Kwon,
1 Young Ju Kim,
1 Young Han Lee,
1 Won-Yeon Lee,
2 and Myung Soon Kim
1
Departments of
1Radiology,
2Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
Received September 5, 2005
Accepted November 23, 2005
Reprint address: requests to Dr. Young Ju Kim, Department of
Radiology, Yonsei University Wonju College of Medicine, 162
Ilsandong, Wonju, Ganwondo 220-701, Korea. Tel: 82-33-741-
1465, Fax: 82-33-732-8281, E-mail: yjkim@yonsei.ac.krWoocheol Kwon, et al.
Yonsei Med J Vol. 47, No. 3, 2006
females, and the average age of the subjects was
46 years (range 18-87 years). Plain chest radio-
graphy and angiographic studies obtained upon
hospitalization were analyzed and interpreted
independently by two radiologists retrospectively.
The diagnosis of tuberculosis as the cause of
hemoptysis was established by either chest
radiography (38/230) or chest radiography and
sputum examination (192/230). Pre-angiogram
bronchoscopy was performed (195/230), as endo-
scopic findings have been useful in ascertaining
the site of bleeding in cases of diffuse lung in-
filtrations.
4
Based on the findings from plain chest radio-
graph, which included the degree of progression
of the tuberculosis, complications, and degree of
pleural involvement, the cases were divided into
four types Type I was tuberculosis without com-
plicated lesions (Fig. 1), Type II consisted of those
cases complicated by conditions such as bron-
chiectasis, aspergilloma, and cavitation (Fig. 2),
Type III consisted of Types I or II in which only
the pleura of the lung apices was involved, and
Type IV was defined as extensive pleural involve-
ment which exceeded the apices (Fig. 3).
Likewise, angiographic findings were divided
into four categories. Group I included cases of
bronchial artery abnormalities only. Group II
consisted of cases involving either the internal
mammary artery or the intercostal artery (Fig.
4A). Group III was defined as either Group I or
Group II and an abnormality of one of the
branches of the subclavian artery, and Group IV
consisted of cases with abnormalities of two or
more branches of the subclavian artery, or any
case in which there were small branches or
blushes that appeared to be collaterals directly
from the main trunk (Fig. 4B). The internal mam-
mary artery, a branch of the subclavian artery,
was included in Group II because it usually
supplies diseased lung parenchyma rather than
Fig. 2. Chest PA shows pulmonary tuberculosis with a
cavitary lesion in the right lung (Type II).
Fig. 3. Destructive change, bronchiectasis, and extensive
pleural invasion are seen on a chest PA (Type IV).
Fig. 1. An angiogram shows pulmonary tuberculosis in
the right upper lung field (Type I). Right intercostobron-
chial angiography shows hypervascularity from the bron-
chial artery (Grade I).The Effectiveness of Embolotherapy in Pulmonary Tuberculosis
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pleural invasion (Fig. 5). Respective Type and
Group data from the patients' charts were com-
pared, and the short- and long-term hemostatic
effects of arterial embolization were analyzed.
Images from arterial embolization were cap-
tured by DSA with the Optimus DVI System and
BV 5000 (Philips, Einthoven, Netherland). Hemor-
rhages were located with the combination of
fiberoptic bronchoscopy, plain chest radiography,
and angiographic findings. Any findings of hyper-
vascularity, hypertrophied vessels, bronchial
artery-pulmonary artery shunt, arterial aneurysm
formation, and extravasation of contrast obtained
from angiography were considered as evidence of
the bleeding site.
Diagnostic angiography was routinely per-
formed to exclude the presence of spinal arteries
arising from the bronchial or intercostal arteries;
spinal arteries were not considered a contrain-
dication for embolization. In such cases, a micro-
catheter catheter tip was positioned distal to the
origin of the spinal artery and large particles
were used. Embolization was performed with
either polyvinyl alcohol (355-500 or 500-710
microns, Contour Emboli, Boston Scientific,
USA), gelfoam, or a combination of both. In
order to prevent the reflux of the embolization
material into the aorta or vertebral artery, the
procedure was performed under close fluoro-
scopic observation with a combination of contrast
materials.
RESULTS
Among the 230 patients, 77 had plain chest
Fig. 5. (A) A Chest PA shows destructive lung parenchyma and pleural invasion in the left upper lung field (Type IV).
(B) A left subclavian angiogram shows a hypertrophied internal mammary artery, shunting, and numerous collaterals with
blushes from main trunk of the subclavian artery (Group IV). (C) The left internal mammary artery supplies a destructive
lung parenchyma rather than the pleural lesion.
Fig. 4. (A) Hypervascularity and shunt-
ing are noted in an angiogram of the
right intercostobronchial (Group II). (B)
A Right subclavian angiogram shows
numerous collateral branches and
shunting from the subclavian artery
(Group IV).
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radiographs classified as Type I, 53 were iden-
tified as Type II, 40 were identified as Type III,
and 60 had Type IV radiographs. Classification
according to abnormal vascular patterns on
angiography yielded 101 patients in Group I, 49
in Group II, 35 in Group III, and 45 in Group IV.
The interrelationship between the plain chest
radiographic findings and abnormal vascular
patterns on angiography is presented in Table 1.
There was no correlation between age and sex
distributions among types of chest radiographs.
The distribution of abnormal angiographic
findings according to chest radiographic classifi-
cation demonstrated an increasing tendency of
aneurysm formation, shunt, and extravasation of
contrast in Type III and Type IV, providing direct
evidence of hemoptysis, in 5 (8%) Type IV
patients only, and not in any of the other Types
(Table 2).
The distribution and frequency of embolization
of the arteries were as follows: bronchial artery,
270 times; intercostal artery, 136 times; internal
mammary artery, 71 times; other subclavian
branches, 106 times; and inferior phrenic artery, 8
times. The average number of embolized vessels
according to Types is as follows; 1.4 of Type I, 1.8
of Type II, 2.7 of Type III, and 4.8 of Type IV.
There were more extensive systemic collateral
supplies in Type III and IV (11 branches/77
patients in Type I, 14/53 in Type II, 31/40 in Type
III, and 121/60 in Type IV) (Table 3). Among 77
patients with failed embolization, 30 underwent
operations (2, 10, 13, and 5 in each Type respec-
tively), 25 expired due to hemoptysis during
hospitalization (10 of Type III and 15 of Type IV),
and 22 were not available for follow up analysis.
There was no re-bleeding after initial arterial
embolization in 73 (92%) of Type I, 52 (80%) of
Type II, 42 (70%) of Type III, and 52 (56%) of Type
IV patients.
These figures represent 219 (75%) out of all 296
patients. Of the 230 patients who were available
for long-term follow-up, the number of those who
did not experience further episodes of hemoptysis
1 year after treatment (long-term hemostatic rate)
was: 62 (80%) of Type I, 41 (77%) of Type II, 25
(62%) of Type III, and 27 (45%) of Type IV patients,
which translates to 155/230 (67%) patients overall
(Table 4). The number of patients who received
surgery as the treatment for re-bleeding was 4/12
(33%) of Type II, 3/15(20%) of Type III, and 2/33
(6%) of Type IV patients; no Type I patients had
surgery.
No major complications such as stroke, trans
Table 2. Angiographic Findings According to Chest Radiographs
Type
I (n = 77) II (n = 53) III (n = 40) IV (n = 60)
Hypervascularity 77 53 23 56
Shunt 8 10 13 48
Aneurysm 0 1 4 19
Extravasation of contrast 0 0 0 5
Table 1. Comparison of Chest Radiographs with Angiographic Findings
Type
I (n = 77) II (n = 53) III (n = 40) IV (n = 60) Total (n = 230)
Group I 66 27 10 8 101
Group II 8 18 11 12 49
Group III 2 5 13 15 35
Group IV 1 3 6 35 45The Effectiveness of Embolotherapy in Pulmonary Tuberculosis
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verse myelitis or bronchial infarction were en-
countered. The anterior spinal artery and the
artery of Adamkiewicz were seen in twelve cases
(5%), either prior to embolization or only after
distal embolization. There were sporadic com-
plaints of chest pain during embolization of
hypertrophied intercostal arteries, but they were
only transient.
DISCUSSION
Ever since Remy et al. first performed a bron-
chial artery embolization to treat hemoptysis in
1974, the procedure has been used to treat both
massive hemoptysis and chronic intermittent
hemoptysis, as well as a preoperative method to
improve the lung function of hemoptysis patients
prior to surgery and as an effective hemostatic
measure in patients for whom surgery is not
possible.
5-8
The therapeutic benefits of arterial embolization
in hemoptysis vary according to different sources,
and depend on a number of factors including the
degree of bleeding, risk of recurrent hemoptysis,
and the overall lung function of the patient. The
severity of hemoptysis cannot be judged by the
volume of bleeding alone, as cases with even mild
bleeding can be fatal if the bleeding is prolonged
for hours or days.
1,7
Pulmonary tuberculosis is the major cause of
hemoptysis. Both active and inactive tuberculosis
can induce hemoptysis. Furthermore, complica-
tions due to tuberculosis such as bronchiectasis,
aspergilloma, lung cancer, chronic bronchitis, lung
abscess, and pneumonia can causes hemoptysis.
Effective chemotherapy has simplified the treat-
ment of pulmonary tuberculosis, and a single
episode of minor hemoptysis is typically either
self-limiting or controllable with antituberculous
medication.
Despite recent advances in treatment, pulmo-
nary tuberculosis-induced chronic inflammatory
disease continues to be the major cause of hemop-
tysis, mainly due to the formation of a bronchial-
pulmonary artery anastomosis within inflamma-
tory tissue in the vicinity of the bronchioles.
Reports show that elevated pressure within the
Table 3. Number of Embolized Vessels According to Type of Pulmonary Tuberculosis
Type
I II III IV
Bronchial artery 85 57 49 88
Intercostal artery 13 23 26 74
Internal mammary artery 5 6 15 45
Thyrocervical artery 2 2 4 20
Thoracoacromial artery 2 2 10 36
Lateral thoracic artery 1 4 2 17
Subscapular artery 1 0 0 3
Inferior phrenic artery 0 2 2 4
Table 4. Hemostatic Effects of Embolization
Hemostasis
Type
I II III IV
Short term (n = 296) 73/79 (92%) 52/65 (80%) 42/60 (70%) 52/92 (56%)
Long term (n = 230) 62/77 (80%) 41/53 (77%) 25/40 (62%) 27/60 (45%)Woocheol Kwon, et al.
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bronchial arteries may result in vascular dilatation
or rupture, leading to chronic extravasation of
blood, pulmonary cavitation, erosion of the neigh-
boring pulmonary artery, or pulmonary artery
aneurysmal rupture due to an arterio-venous
fistula.
2,3 Therefore, aside from medical therapy
based on anti-tuberculous medication alone, ag-
gressive treatment modalities such as bronchial
artery embolization or definitive resection of the
lesion are necessary.
8-10
In this study, the relationship between plain
chest radiograph findings and abnormal vascular
distribution on angiography of pulmonary tuber-
culosis patients were compared among four types
and groups. We found that when compared to
tuberculosis without complications (Type I), tu-
berculosis accompanied by complications such as
bronchiectasis, aspergilloma, and cavitation, etc.
(Type II), tuberculosis with limited pleural inva-
sion (Type III) and tuberculosis with widespread
pleural involvement (Type IV) all had more in-
volvement of the systemic collateral arteries than
that of the bronchial or intercostal arteries; there
were more abnormal vessels as well.
An angiographic finding of hypervascularity
was evident in all of the cases, and was the most
commonly observed indirect sign of hemorrhage.
Vascular hypertrophy was present with increasing
frequency as the cases progressed from Type I to
Type IV. Arterial aneurysm formation was rarely
observed in Types I or II, but was rather common
in Types III and IV. One of the direct signs of
hemoptysis, extravasation of contrast, was evident
in only 5 Type IV cases, suggesting that extravasa-
tion is primarily observed in cases of widespread
pleural involvement of tuberculosis. However,
because the interrelationship between extravasa-
tion of contrast and findings of plain chest radio-
graphs of pulmonary tuberculosis had not been
investigated prior to the present study, we were
unable to compare our results with those of
others. Arterial embolization in Type I cases was
carried out primarily in the bronchial artery,
although in some cases it was carried out in the
intercostal artery and internal mammary artery.
Patients with Type IV chest radiographs had
increased systemic collateral vasculature; branches
of the subclavian artery were used frequently as
the site of embolization in Type IV patients. The
parietal pleura is supplied by intercostal, internal
mammary, and musculophrenic arteries, whereas
the visceral pleura derives its arterial supply from
the bronchial arteries. Patients with pleural dis-
ease in association with parenchymal abnorma-
lities are more likely to have nonbronchial
systemic collateral vessels supplying the bleeding
area.
11 These findings also suggest that small
arteries, which were not initially important, grew
into the systemic circulation before embolization
supplied a large amount of blood into the lesion,
and therefore increased the risk of re-hemor-
rhage.
12 Furthermore, the underlying lesion of
pulmonary tuberculosis may progress by a similar
mechanism, even after bronchial artery emboliza-
tion.
There have been many reports on the effec-
tiveness of embolization of hemostasis, and
reports on the early hemostatic results include
success rates ranging from 73-91%. Continued fol-
low-up after embolization has yielded long-term
hemostatic success rates of 72-80% in the litera-
ture.
9-19 In our study, the short- and long-term
hemostatic rates were 73% and 67%, respectively.
While these figures are lower overall than pre-
viously published results, one should keep in
mind that the subjects of this study were patients
whose hemoptysis was due to pulmonary tuber-
culosis only, and included Type IV patients with
increased systemic circulation whose early hemo-
static rate was 56% and long-term hemostatic rate
45%. Considering that patients in the Type I cate-
gory, who rarely show signs of systemic collateral
circulation, had short- and long-term hemostatic
rates of 92% and 80%, respectively, similar to the
results of previous literatures, the presence of
systemic collateral circulation has an enormous
influence on the hemostatic outcome after embo-
lization.
17-21
We have limited out discussion to the degree
of lung damage due to the cause of the hemop-
tysis, pulmonary tuberculosis, and the severity of
pleural involvement as seen on plain chest radio-
graphy, the distribution of abnormal vascularity
on angiography, the interrelationship between the
latter two findings, and the hemostatic results of
embolization. As such, the size and other dimen-
sions of the embolization materials used in this
study were not included. We devised a novelThe Effectiveness of Embolotherapy in Pulmonary Tuberculosis
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classification system for the degree of lung lesion,
pleural involvement, and abnormal vascularity on
angiography studies. We expect that this infor-
mation will aid in the prediction of both early and
late hemostatic results of arterial embolization for
pulmonary tuberculosis patients with hemoptysis,
and in the selection of patients who are candidates
for aggressive treatment measures such as sur-
gery.
In conclusion, we confirmed that when com-
pared to cases of simple pulmonary tuberculosis
or tuberculosis complicated by bronchiectasis, as-
pergilloma, or cavitation, more systemic collateral
circulation existed in cases of tuberculosis accom-
panied by widespread pleural involvement. Such
cases with extensive pleural involvement also had
more frequent abnormal vascular findings on
angiography, showed direct evidence of hemop-
tysis such as the extravasation of contrast mate-
rial, and displayed relatively lower early and
long-term hemostatic effects after embolization.
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